Harvard Study Shows AI Outperforms Doctors in Diagnosis
Boston, Massachusetts, United States | April 30, 2026 A new study led by researchers at Harvard Medical School and...
AI drug discovery Alzheimer’s Disease Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
Boston, Massachusetts, United States | April 30, 2026 A new study led by researchers at Harvard Medical School and...
NEW YORK, April 29, 2026 Aidoc has announced the successful completion of a $150 million Series E funding round...
WASHINGTON & COLUMBUS, OHIO, April 28, 2026 Paradigm Health has announced a landmark research collaboration with the U.S. Food...
SAN CARLOS, CALIFORNIA, April 29, 2026 Earflo has announced the FDA clearance and U.S. market availability of its innovative...
NEW YORK, NY, April 27, 2026 TytoCare has achieved a major regulatory milestone with the U.S. Food and Drug...
AUSTIN, Texas, April 20, 2026 Oracle Health announced a major milestone in healthcare interoperability and digital transformation, achieving designation...
EDMONTON, Alberta, April 20, 2026 Nanostics Inc. has announced the publication of a peer-reviewed study validating its AI-powered ClarityDX®...
San Mateo, California & Chicago, Illinois, U.S. | April 15, 2026 Cala Health has announced a major regulatory milestone...
Raleigh, North Carolina | April 13, 2026 Endpoint Clinical has announced the release of Elosity® R3, a major upgrade...
April 7, 2026 — Global HeartFocus, developed by DESKi, in partnership with Inteleos®, has launched the first AI-enabled cardiac...
